The results showed that siSLC25A26 treatment canceled the inhibitory effect of CTB on HCC cells methionine cycle, which were confirmed after analyzing of methionine cycle metabolism rate-limiting enzyme MAT2A by western blot and real-time PCR (Fig. 5D, E). The gene discussed is MAT2A; the disease is hepatocellular carcinoma.